HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability.

Abstract
Tumor necrosis factor (TNF)-alpha, a major proinflammatory cytokine, triggers endothelial cell activation and barrier dysfunction which are implicated in the pathogenesis of pulmonary edema associated with acute lung injury syndromes. The mechanisms of TNF-alpha-induced vascular permeability are not completely understood. Our initial experiments demonstrated that TNF-alpha-induced decreases in transendothelial electrical resistance across human pulmonary artery endothelial cells are independent of myosin light chain phosphorylation catalyzed by either myosin light chain kinase or Rho kinase. We next assessed the involvement of another cytoskeletal component, the tubulin-based microtubule network, and found TNF-alpha to induce a decrease in stable tubulin content and partial dissolution of peripheral microtubule network as evidenced by anti-acetylated tubulin and anti-beta-tubulin immunofluorescent staining, respectively. Microtubule-stabilizing agents, paclitaxel and epothilone B, significantly attenuated TNF-alpha-induced decreases in transendothelial electrical resistance, inhibited the cytokine-induced increases in actin stress fibers, formation of intercellular gap, and restored the TNF-alpha-compromised vascular endothelial (VE)-cadherin-based cell-cell junctions. Importantly, neither TNF-alpha nor paclitaxel treatment was associated with endothelial cell apoptosis. Inhibition of p38 mitogen-activated protein kinase by SB203580 significantly attenuated TNF-alpha-induced microtubule destabilization, actin rearrangement, and endothelial barrier dysfunction. These results strongly suggest the involvement of microtubule rearrangement in TNF-alpha-induced endothelial cell permeability via p38 mitogen-activated protein kinase activation.
AuthorsIrina Petrache, Anna Birukova, Sarah I Ramirez, Joe G N Garcia, Alexander D Verin
JournalAmerican journal of respiratory cell and molecular biology (Am J Respir Cell Mol Biol) Vol. 28 Issue 5 Pg. 574-81 (May 2003) ISSN: 1044-1549 [Print] United States
PMID12707013 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Actins
  • Antineoplastic Agents, Phytogenic
  • Enzyme Inhibitors
  • Imidazoles
  • Pyridines
  • Tumor Necrosis Factor-alpha
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580
  • Paclitaxel
Topics
  • Actins (metabolism)
  • Adherens Junctions (metabolism)
  • Animals
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Apoptosis (physiology)
  • Cells, Cultured
  • Cytoskeleton (metabolism)
  • Electric Impedance
  • Endothelium, Vascular (cytology, drug effects, metabolism)
  • Enzyme Activation
  • Enzyme Inhibitors (pharmacology)
  • Humans
  • Imidazoles (pharmacology)
  • Immunohistochemistry
  • Microtubules (metabolism)
  • Mitogen-Activated Protein Kinases (metabolism)
  • Paclitaxel (pharmacology)
  • Pulmonary Artery
  • Pyridines (pharmacology)
  • Tumor Necrosis Factor-alpha (pharmacology)
  • p38 Mitogen-Activated Protein Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: